Placing greater focus on patient experience can build trust between consumers and healthcare organizations, which important for the effectiveness of the healthcare system, said Ashish K. Jha, MD, of the Harvard T.H. Chan School of Public Health.
Placing greater focus on patient experience can build trust between consumers and healthcare organizations, which important for the effectiveness of the healthcare system, said Ashish K. Jha, MD, professor of health policy at the Harvard T.H. Chan School of Public Health.
Transcript (slightly modified)
If there is empirical evidence that providers with higher patient satisfaction tend to score highly on measures of care processes and outcomes, then why is the use of patient experience as a quality metric so controversial?
So the use of patient experience as a quality measure has been controversial, I think, for a couple of reasons: One, is a lot of doctors and nurses misperceive it as being somehow a measure of satisfaction. It’s actually not patient satisfaction, it’s patient experience, and they really are different things.
The truth is that we don’t want to turn healthcare into a sort of service, the way restaurants and hotels are services. We think there is something special about healthcare. I agree, I think there is something special about healthcare. But getting the experience of individual patients, and measuring it, and focusing on that I think is a really important component of what high-quality healthcare looks like.
In your commentary for AJMC, you point out that including patient experience in value-based payment programs builds trust in the healthcare system. How will providers and health systems benefit from this increased trust?
So there are several reasons why that increased trust that comes out of focusing on patient experience will benefit both providers and patients. I mean fundamentally, as a doctor, I am in the business not just of making a diagnosis and prescribing the right treatment, but it’s really about building a partnership with the patient, ensuring that the patient takes the medications over the long run, comes back if there are complications, all of that is built on trust. And if the provider of the organization, if doctors, if hospitals, are not focused on the experience that the patients have, that trust is diminished, and the effectiveness of healthcare is substantially reduced.
You have voiced concerns about the lack of socioeconomic status (SES) adjustment in the Hospital Readmissions Reduction Program, but in the past you were against the adjustment. What are the 2 sides of the argument and what, ultimately, changed your mind?
So the fundamental misunderstanding that a lot of people have about SES adjustment—I used to have this as well—is that they think that SES adjustment means you’re giving credit to providers for providing bad care to poor people.
That’s actually not necessarily true at all. The bottom line is that if I’m a healthcare organization and I do a very bad job of providing care to poor people, and everybody around me does a much better job, SES adjustment is not going to bail me out. One of the things that I learned along the way is that fundamentally what SES adjustment is doing is it’s equalizing populations. It’s not penalizing an organization because they have more poor people.
Look, we want to penalize organizations that provide bad care to poor people. We don’t want to penalize them just for having more poor people. That’s what the readmissions penalty program does right now and what we need to do is account for SES so that everybody is on the same playing field.
LLMs Show Promise, But Challenges Remain in Improving Inefficient Clinical Trial Screening
July 31st 2025Large language models (LLMs) such as GPT-3.5 and GPT-4 may offer a solution to the costly and inefficient process of manual clinical trial screening, which is often hindered by the inability of structured electronic health record data to capture all necessary criteria.
Read More
Trends in Insulin Out-of-Pocket Costs and Use Disparities, 2008-2021
July 31st 2025Given trends in cost and use, insulin out-of-pocket cost reduction policies would be more efficient if they targeted members in high-deductible health plans with savings options and low-income patients.
Read More
Laundromats as a New Frontier in Community Health, Medicaid Outreach
May 29th 2025Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.
Listen
Specialty Drug Costs Drive Medicare Part D Dermatology Expenditures
July 22nd 2025The rapidly increasing prescriptions for expensive specialty medications, rather than their price growth, are the primary driver of escalating dermatology Medicare Part D expenditures, necessitating policies that balance innovation, access, and affordability.
Read More